Business

April 1, 2014 8:44 AM

Heat Biologics reports wider net loss in 2013

Heat Biologics reported a wider net loss in 2013 that it attributed to an increase in both research and development and clinical and regulatory expenses.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos